Maráz A - Search Results

1

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma.

Maráz A, Cserháti A, Uhercsák G, Szilágyi É, Varga Z, Révész J, Kószó R, Varga L, Kahán Z. Maráz A, et al. BMC Cancer. 2018 Mar 15;18(1):296. doi: 10.1186/s12885-018-4209-9. BMC Cancer. 2018. PMID: 29544452 Free PMC article.

2

[Novelties in the treatment for advanced renal-cell cancer].

Maráz A. Maráz A. Orv Hetil. 2011 Apr 24;152(17):655-62. doi: 10.1556/OH.2011.29100. Orv Hetil. 2011. PMID: 21464023 Review. Hungarian.

3

Roles of BCL-2 and MDR1 expression in the efficacy of paclitaxel-based lung cancer chemoradiation.

Maráz A, Furák J, Pálföldi R, Eller J, Szántó E, Kahán Z, Thurzó L, Molnár J, Tiszlavicz L, Hideghéty K. Maráz A, et al. Anticancer Res. 2011 Apr;31(4):1431-6. Anticancer Res. 2011. PMID: 21508398

4

A prospective study of supine versus prone positioning and whole-body thermoplastic mask fixation for craniospinal radiotherapy in adult patients.

Hideghéty K, Cserháti A, Nagy Z, Varga Z, Fodor E, Vincze V, Szántó E, Maráz A, Thurzó L. Hideghéty K, et al. Among authors: maraz a. Radiother Oncol. 2012 Feb;102(2):214-8. doi: 10.1016/j.radonc.2011.07.003. Epub 2011 Aug 19. Radiother Oncol. 2012. PMID: 21862161 Free article.

5

Thrombocytosis has a negative prognostic value in lung cancer.

Maráz A, Furák J, Varga Z, Kahán Z, Tiszlavicz L, Hideghéty K. Maráz A, et al. Anticancer Res. 2013 Apr;33(4):1725-9. Anticancer Res. 2013. PMID: 23564823

6

Acute oesophageal toxicity related to paclitaxel-based concurrent chemoradiotherapy for non-small cell lung cancer.

Maráz A, Furák J, Varga Z, Fodor E, Együd Z, Borzási E, Kahán Z, Pálföldi R, Tiszlavicz L, Hideghéty K. Maráz A, et al. Anticancer Res. 2013 Apr;33(4):1737-41. Anticancer Res. 2013. PMID: 23564825

7

[First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer].

Maráz A, Bodrogi I, Csejtei A, Dank M, Géczi L, Küronya Z, Mangel L, Petrányi A, Szûcs M, Bodoky G. Maráz A, et al. Magy Onkol. 2013 Sep;57(3):173-6. Epub 2013 Aug 9. Magy Onkol. 2013. PMID: 24107823 Free article. Hungarian.

8

[Experience with everolimus therapy for patients with metastatic renal cancer in Hungary].

Maráz A, Bodoky G, Dank M, Géczi L, Kahán Z, Mangel L, Révész J, Szűcs M. Maráz A, et al. Magy Onkol. 2014 Mar;58(1):4-9. Epub 2014 Mar 4. Magy Onkol. 2014. PMID: 24712001 Free article. Hungarian.

9

[Therapeutic significance of sunitinib-induced "off-target" side effects].

Maráz A, Cserháti A, Uhercsák G, Szilágyi E, Varga Z, Kahán Z. Maráz A, et al. Magy Onkol. 2014 Sep;58(3):167-72. Epub 2014 Aug 2. Magy Onkol. 2014. PMID: 25260080 Free article. Hungarian.

10

[Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].

Hideghéty K, Cserháti A, Besenyi Z, Zag L, Gaál S, Együd Z, Mózes P, Szántó E, Csenki M, Rusz O, Varga Z, Dobi Á, Maráz A, Pávics L, Lengyel Z. Hideghéty K, et al. Among authors: maraz a. Magy Onkol. 2015 Jun;59(2):103-10. Epub 2015 Mar 11. Magy Onkol. 2015. PMID: 26035157 Free article. Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page